Dear Colleagues,

Welcome to our meeting in pharmacology. Various progresses

in medical world have been made including newly developed
drugs, management strategy and the accompanying sophisti- Submission Deadline:
cated techniques. In order to keep pace with the rapid deve-
lopment, we are trying to provide this seminar with the latest
March 7th 2020
issues in medicine. Latest issues do not only include new drugs,
but also established drugs with newly invented mechanism or Theme: original research, case studies and The 18th Annual Scientific Meeting
broadened indication. new techniques of investigation
The scope of the present seminar includes management of a
variety of diseases like cardiovascular diseases, respiratory The abstract either in English or Bahasa Indonesia on Pharmacology and Therapy
diseases, metabolic, musculoskeletal problems, infectious di- should contain a maximum of 250 words and
seases, hormones, biosimilars and health policy. In addition to state the following:
proper management of patients, the presentations will also  Poster project/initiative title
cover topics to increase our ability in establishing the diagno-  Affiliation who initiated the project
sis and prognosis.  Description of project
Finally, we would like to thank our participants, invited spea-  Outcomes/conclusions of project
kers and moderators for sharing experiences, and sponsors for
their kind help and financial support. • Send your abstract to
It is great to have you with us and we do hope that this scien- pit.farmakologi@gmail.com
tific meeting will be fruitful to all of you. • Selection notification via email is on March
13th, 2020
~ The Committee ~ • The accepted abstract with full paper will be Update in Pharmacology:
included in the proceeding book (with ISSN).
• Five (5) best papers will be published in Na- Recent Development in Drug Treatment
http://bit.ly/ tional Journal (with SKP IDI/IAI)
and Clinical Management
pitfarmakologi
Free registration participants MUST:
• Register via online before March March 27-28, 2020
26th, 2020.
• Bring the invitation brochure for
Re-registration on the D-day.
10 SKP IDI


General
Students (copy ID)
IDR 800.000
IDR 600.000
8 SKP IAI
Secretariat:
Medya (0857 8045 9122)
Transfer to 0344497613 Syania (0855 9121 1538) Hotel Lumire, Ballroom 2nd Fl.
Yayasan Pengembangan Farmakologi Fitri (0812 1376 7599)
Jl. Senen Raya No.135, Jakarta Pusat
BNI 46 Cabang UI Depok Telp: 021-31930481; Fax: 021-3920947
Email: pit.farmakologi@gmail.com
 Friday, March 27
07.30-08.15 Re-registration and coffee morning
08.15-08.30 Opening Remarks and Pretest
08.30-09.00 Research presentation 1:
Development, characterization and
pharmacokinetic profile of curcumin nanoparticles
Ni Made Dwi Sandhiutami, S.Si, M.Kes
09.00-09.30 Lecture 1: The ethical aspects in
collaboration between medical doctors and
industries in advertisement
Prof. Dr. dr. Rianto Setiabudy, Sp.FK
09.30-10.30 Simposium 1: Parenteral nutrition
 Updates in nutrition practice in critical illness
dr. Fiastuti Witjaksono, Sp.GK
10.30-11.30 Simposium 2: Antimicrotubulin agent for
cancer treatment
 The role of antimicrotubulin agent: focus on eribulin in
cancer therapy. Prof. Dr. dr. Rianto Setiabudy, Sp.FK
 Eribulin treatment in soft tissue sarcoma, beyond first
line: case sharing. dr. Nadia A. Mulansari, Sp.PD-KHOM
11.30-13.30 Friday Prayer and Lunch
13.30-14.30 Simposium 3: The new era in gout
management
 Clinical approach and management of hyperuricemia
and gout arthritis. dr. Anna Ariane, Sp.PD-KR
 Current treatment options in gout management
Prof. Dr. dr. Rianto Setiabudy, Sp.FK
14.30-15.30 Simposium 4: Antimicrotubulin agent for
cancer treatment
 The role of antimicrotubulin agent: focus on eribulin in
cancer therapy. Prof. Dr. dr. Rianto Setiabudy, Sp.FK
 Eribulin treatment in soft tissue sarcoma, beyond first
line: case sharing. dr. Nadia A. Mulansari, Sp.PD-KHOM
15.30-16.30 Simposium 5: From safety to benefit:
the unexpected legacy of T2D CVOTs
 New perspectives on recent cardiovascular outcome
trial: focus on Empagliflozin
Prof. Dra. Arini Setiawati, Ph.D
 Cost-effectiveness of Empagliflozin for the treatment of
type 2 diabetes mellitus at high cardiovascular risk
Prof. Dr. Dra. Erna Kristin, Apt, M.Si
16.30-17.00 Coffee and Door Prize Day-1
Moderators
Dr. dr. Anggi Gayatri, Sp.FK
Dr. Dra. Ari Estuningtyas, M.Biomed
Prof. Dr. dr. Armen Muchtar, Sp.FK
Dr. dr. Dewi Selvina Rosdiana, M.Kes
Prof. dr. Frans D. Suyatna, Ph.D, Sp.FK
dr. Instiaty, Ph.D, Sp.FK
dr. Nafrialdi, Ph.D, Sp.PD
Prof. Dr. dr. Purwantyastuti, M.Sc, Sp.FK
Dr. Melva Louisa, S.Si, M.Biomed
dr. Suharti K. Suherman, Sp.FK
dr. Vivian Soetikno, Ph.D, Sp.FK
dr. Wawaimuli Arozal, M.Biomed, Ph.D
Dr. Zunilda Dj. Sadikin, MS, Sp.FK
Saturday, March 28
07.30-08.00 Coffee morning
08.00-08.30 Research presentation 2:
Pharmacometrics: alternative approach of
quantitative pharmacology Dr. dr. Anggi Gayatri, Sp.FK
08.30-09.00 Lecture 2: The role of clinical
pharmacology in patient safety
dr. Nafrialdi, Ph.D, Sp.PD
09.00-10.00 Simposium 6: The novel targeted therapy in
differentiated thyroid carcinoma
 Perspective in the use of Lenvatinib in differentiated
thyroid carcinoma. Prof. Dra. Arini Setiawati, Ph.D
 Lenvatinib: a new targeted therapy for differentiated
thyroid carcinoma: case sharing
dr. Eko Purnomo, Sp.KN
Saturday, March 28
10.00-11.00 Simposium 7: Access and innovation in
cancer management: can we elaborate?
 Treatment access and innovation medicines in cancer
management
Prof. dr. Iwan Dwipraharto, M.Med.Sc, Ph.D
 A new standard care in the treatment of NSCLC
Prof. dr. Abdul Muthalib, Sp.PD-KHOM
11.00-12.00 Simposium 8: Semaglutide-new once
weekly glucose lowering drug
 Semaglutide-the next generation of GLP-1RA
Prof. Dr. dr. Rianto Setiabudy, Sp.FK
 Semaglutide-the SUSTAIN clinical trial program
Prof. Dr. dr. Pradana Soewondo, Sp.PD-KEMD
12.00-13.00 Prayer and Lunch
13.00-14.00 Simposium 9: Innovative treatment
paradigms in diabetes management:
insulin innovation
 Rational therapy with basal insulin in type 2 diabetes
mellitus according to 2019 Guideline
Prof. Dr. dr. Sarwono Warpadji, Sp.PD-KEMD
 Better diabetes control with novel basal insulin: a real
world solution
Prof. Dr. dr. Pradana Soewondo, Sp.PD-KEMD
14.00-15.00 Simposium 10: The role of CCBs in
hypertension
 Disease and Guideline InaSH
dr. Nafrialdi, Ph.D, Sp.PD
 Adalat Oros: not all CCBs are equal
Prof. Dra. Arini Setiawati, Ph.D
15.00-16.00 Simposium 11: Reframing asthma care
 The importance of antiinflammatory agents: a paradigm
shift in asthma management
dr. Triya Damayanti, Ph.D, Sp.P(K)
 Asthma exacerbation management update: the use of
inhaled corticosteroid
dr. Budhi Antariksa, Ph.D, Sp.P(K)
16.00-16.30 Coffee and Door Prize Day-2